3-D Matrix, Ltd. (TYO:7777)

Market Cap	46.33B +36.5%
Revenue (ttm)	11.92B +55.9%
Net Income	3.69B
EPS	27.26
Shares Out	127.98M
PE Ratio	13.28
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,061,200
Open	357.00
Previous Close	363.00
Day's Range	351.00 - 366.00
52-Week Range	290.00 - 793.00
Beta	0.99
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 11, 2026

About 3-D Matrix

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields; and surfactant-like peptide, as well as High Concentration PuraMatrix, a high concentration hydrogel; and GMP Grade PuraMatrix. The company was incorporated in 2004 and is based in Tokyo, Japan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 129
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7777

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 26, 2026

Data Sources Report a data error